Immune-regulatory mechanisms of drug-free remission in rheumatoid arthritis (RA) are
unknown. We hypothesized that synovial tissue macrophages (STM), which persist in remission, …

Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without
previous knowledge of target expression levels in the diseased tissue. Approximately 40% of …

Accumulation of lactate in the tissue microenvironment is a feature of both inflammatory
disease and cancer. Here, we assess the response of immune cells to lactate in the context of …

Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …

There is a current imperative to unravel the hierarchy of molecular pathways that drive the
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …

Background— Immunoglobulin M (IgM) natural antibodies bind oxidatively-modified low-density
lipoprotein (LDL) and apoptotic cells and have been implicated as being important for …

In this in-depth review, we examine the worldwide epidemiology of SLE and summarize
current knowledge on the influence of race/ethnicity on clinical manifestations, disease activity, …

Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation
and destruction 1 . There is currently no cure for rheumatoid arthritis, and the effectiveness of …

Biomarkers are needed for predicting the effectiveness of disease modifying antirheumatic
drugs (DMARDs). Here, using functional lipid mediator profiling and deeply phenotyped …

UBE2L3 is associated with increased susceptibility to numerous autoimmune diseases, but
the underlying mechanism is unexplained. By using data from a genome-wide association …